# US 2025/0144383 A1 · Inner ear device with access and passive components

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0144383 A1
- Document ID: US20250144383A1
- Status: Published application
- Kind: A1
- Application number: 18/684,331
- Filed: 2022-08-20
- Published: 2025-05-08
- Earliest claimed: 2021-08-20
- Assignees: Cochlear Limited
- Applicants: Cochlear Limited
- Inventors: Wolfram Frederik DUECK; Daniel SMYTH
- Web page: https://patentgrep.com/patent/US20250144383A1

## CPC

- A61M 31/002: {Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time (artificial gland structures or devices A61F2/022; intra-uterine contraceptive devices A61F6/14; tampons for introducing into the vagina A61F13/20, A61L15/00; suppositories or bougies for intra-vaginal or intra-uterine application A61K9/02; physical forms of medicinal preparations for sustained or differential drug release A61K9/20, A61K9/50)}
- A61N 1/36038: {Cochlear stimulation}
- A61F 11/202: {Surgical middle-ear ventilation or drainage, e.g. permanent; Implants therefor}
- A61F 2/14: Eye parts, e.g. lenses or corneal implants; Artificial eyes
- A61M 2202/0007: introduced into the body
- A61M 2205/04: implanted
- A61M 2205/3331: Pressure; Flow
- A61M 2210/0668: Middle ear
- A61N 1/36036: {of the outer, middle or inner ear}
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

A device including a tissue interface portion configured for securement to tissue of and/or proximate an inner ear of a human and provide a passage from outside the inner ear to inside the inner ear and a component releasably attached to the tissue interface portion and/or a portion of the device supported by the tissue interface portion, wherein the device is configured to enable the component to be removed from the tissue interface portion when the tissue interface portion is removably permanently fixed to the barrier establishing the inner ear of a human, and the component at least partially seals the passage and provides one or more passive features.

## Claims

### Claim 1

A device, comprising:
a tissue interface portion configured for securement to tissue of and/or proximate an inner ear of a human and provide a passage from outside the inner ear to inside the inner ear; and
a component releasably attached to the tissue interface portion and/or a portion of the device supported by the tissue interface portion, wherein
the device is configured to enable the component to be removed from the tissue interface portion when the tissue interface portion is removably permanently fixed to the barrier establishing the inner ear of a human, and
the component at least partially seals the passage and provides one or more passive features.

### Claim 2 (depends on 1)

The device of claim 1, wherein:
the component is a therapeutic substance delivery device.

### Claim 3 (depends on 1)

The device of claim 1, wherein:
the component is an artificial round window.

### Claim at position 4

4-5. (canceled)

### Claim 6 (depends on 1)

The device of claim 1, further comprising:
a guide configured to guide a tip of a termination of a syringe located outside the inner ear to the septum and/or a passage of the tissue interface portion leading to the septum.

### Claim 7

(canceled)

### Claim 8 (depends on 1)

The device of claim 1, wherein:
the component is a therapeutic substance delivery apparatus;
the device is configured so that a water-based substance natural to the inner ear can enter the delivery apparatus;
the delivery apparatus is configured so that an internal pressure of the delivery apparatus is increased due to the entry of the water-based substance, which pressure increase results in delivery from the delivery apparatus of the therapeutic substance into the inner ear.

### Claim 9 (depends on 1)

The device of claim 1, wherein:
the tissue interface portion has been implanted into bone establishing a barrier between the middle ear and the inner ear for at least 2 years; and
the component was implanted for at least eighteen months less than the tissue interfacing portion.

### Claim 10 (depends on 1)

The device of claim 1, wherein:
the component completely seals the passage.

### Claim 11

A system, comprising:
a tissue interface apparatus through which a passage extends, wherein the tissue interface apparatus is configured to permanently fix to an opening in a barrier between a middle ear and an inner ear of a human such that the passage extends from the middle ear to the inner ear; and
a first functional component at least partially located in the passage, wherein
at least one of:
the first functional component is a passive first functional component detachably attached directly or indirectly to the tissue interface apparatus and removal of the first component provides physical access from the middle ear into the inner ear through the passage, wherein the first functional component at least partially seals the passage in addition to providing a passive feature;
the tissue interface apparatus includes a second passage that is unsealably sealed, the second passage providing physical access from the middle ear into the inner ear through the second passage bypassing the first functional component; or
the first functional component has a passage that is unsealably sealed, the passage of the first functional component providing physical access from a middle ear facing side to an inner ear facing side when unsealed with the first functional component in the passage of the tissue interface apparatus.

### Claim 12 (depends on 11)

The system of claim 11, wherein:
the first functional component is the passive first functional component detachably attached directly or indirectly to the tissue interface apparatus and removal of the first component provides physical access from the middle ear into the inner ear through the passage, wherein the first functional component at least partially seals the passage in addition to providing a passive feature;
the first function component is an artificial round window; and
the inner ear barrier tissue interface apparatus is located at a natural round window location of a human and the artificial round window replaces a natural round window of the person.

### Claim 13 (depends on 11)

The system of claim 11, wherein:
the first functional component is the passive first functional component detachably attached directly or indirectly to the tissue interface apparatus and removal of the first component provides physical access from the middle ear into the inner ear through the passage, wherein the first functional component at least partially seals the passage in addition to providing a passive feature; and
the first functional component is a passive drug-release device.

### Claim 14 (depends on 11)

The system of claim 11, wherein:
the first functional component is the passive first functional component detachably attached directly or indirectly to the tissue interface apparatus and removal of the first component provides physical access from the middle ear into the inner ear through the passage, wherein the first functional component at least partially seals the passage in addition to providing a passive feature; and
the first functional component is a self-healing septum.

### Claim 15 (depends on 11)

The system of claim 11, wherein:
the first functional component is the passive first functional component detachably attached directly or indirectly to the tissue interface apparatus and removal of the first component provides physical access from the middle ear into the inner ear through the passage, wherein the first functional component at least partially seals the passage in addition to providing a passive feature; and
the first functional component is a therapeutic substance containing reservoir that is compressible due to atmospheric pressure increase in the middle ear, wherein compression of the first component due to the atmospheric pressure increase in the middle ear drives a therapeutic substance contained in the reservoir into the inner ear.

### Claim 16 (depends on 11)

The system of claim 11, wherein:
the first functional component is the passive first functional component detachably attached directly or indirectly to the tissue interface apparatus and removal of the first component provides physical access from the middle ear into the inner ear through the passage, wherein the first functional component at least partially seals the passage in addition to providing a passive feature; and
the first functional component is a therapeutic substance containing reservoir that has a self-healing septum facing the middle ear when attached to the inner ear barrier tissue interface and is in fluid communication with the passage.

### Claim at position 16

17-19. (canceled)

### Claim 20 (depends on 11)

The system of claim 11, wherein:
the first functional component has the passage that is unsealably sealed, the passage of the first component providing physical access from the middle ear facing side to the inner ear facing side when unsealed with the first functional component in the passage of the inner ear barrier tissue interface apparatus.

### Claim at position 18

21-30. (canceled)

### Claim 31

A device, comprising:
a tissue interface portion configured for securement to tissue of and/or proximate an inner ear of a human and provide a passage from outside the inner ear to inside the inner ear;
a removable seal apparatus configured to unsealably seal the passage; and
a component releasably attached to the tissue interface portion and/or a portion of the device supported by the tissue interface portion, the component providing one or more passive features, wherein
the device is configured to enable the component to be removed from the tissue interface portion when the tissue interface portion is removably permanently fixed to the barrier establishing the inner ear of a human.

### Claim 32 (depends on 31)

The device of claim 31, wherein:
the component is a therapeutic substance delivery device.

### Claim 33

(canceled)

### Claim 34 (depends on 31)

The device of claim 31, wherein:
the component is a self-healing septum.

### Claim 35

(canceled)

### Claim 36 (depends on 31)

The device of claim 31, further comprising:
a termination over-insertion prevention device configured to prevent over insertion of a termination of a syringe extended through the septum into the inner ear.

### Claim 37 (depends on 31)

The device of claim 31, wherein:
the component is a therapeutic substance delivery apparatus;
the device is configured so that a water-based substance natural to the inner ear can enter the delivery apparatus;
the delivery apparatus is configured so that an internal pressure of the delivery apparatus is increased due to the entry of the water-based substance, which pressure increase results in delivery from the delivery apparatus of the therapeutic substance into the inner ear.

### Claim 38 (depends on 31)

The device of claim 31, wherein:
the tissue interface portion has been implanted into bone establishing a barrier between the middle ear and the inner ear for at least 2 years; and
the component was implanted for at least eighteen months less than the tissue interfacing portion.

### Claim at position 27

39-60. (canceled)
